Edgewise Reports $1.17 Billion Third-Quarter Net Income
Edgewise reported third-quarter 2026 net income of $1.17 billion, versus a $40.7 million net loss a year earlier, reflecting a gain on the sale of its sevasemten program and muscular dystrophy business. Cash, cash equivalents and marketable securities totaled $1.74 billion at quarter-end.
Edgewise reported third-quarter 2026 net income of $1.17 billion, compared with a $40.7 million net loss a year earlier, reflecting a gain on the sale of its sevasemten program and muscular dystrophy business. The company ended September with $1.74 billion in cash, cash equivalents and marketable s…